Proqr Therapeutics Bv Stock Price History

Below is the normalized historical share price chart for ProQR Therapeutics BV extending back to September 18, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ProQR Therapeutics stands at 2.33, as last reported on the 1st of March, with the highest price reaching 2.41 and the lowest price hitting 2.30 during the day. If you're considering investing in ProQR Stock, it is important to understand the factors that can impact its price. ProQR Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.12, which implies the firm had a -0.12 % return per unit of risk over the last 3 months. ProQR Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ProQR Therapeutics' Risk Adjusted Performance of (0.07), coefficient of variation of (941.25), and Variance of 26.65 to confirm the risk estimate we provide. At this time, ProQR Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 03/01/2025, Common Stock Shares Outstanding is likely to grow to about 97.8 M, while Liabilities And Stockholders Equity is likely to drop slightly above 108.5 M. . At this time, ProQR Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 03/01/2025, Price Earnings To Growth Ratio is likely to grow to 0.10, while Price Earnings Ratio is likely to drop (4.88). ProQR Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.121

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns			PRQR

Estimated Market Risk

Expected Return

Risk-Adjusted Return